2025-08-19 | Company
Sustainability report 2024
Sever Pharma Solutions is pleased to announce the publication of its Sustainability Report 2024, highlighting our ongoing commitment to responsible business practices and sustainable growth.
2025-08-19 | Company
Sever Pharma Solutions is pleased to announce the publication of its Sustainability Report 2024, highlighting our ongoing commitment to responsible business practices and sustainable growth.
2025-08-14 | Company
Sever Pharma Solutions has made an expanded agreement with Silo Pharma, Inc. (Nasdaq: SILO).
2025-07-02 | Company
We are pleased to announce the appointment of Fredrik Hultenius as new Chief Executive Officer, effective July 1st, 2025.
2025-06-30 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-06-17 | Company
We’re delighted to share insights from Tony Listro, VP and Site Head of Sever Pharma Solution following a great interview at BIO2025.
2025-04-23 | Company
In 2024, our Putnam site fully commissioned and qualified two new High Potent API processing suites.
2025-04-07 | Company
Sever Pharma Solutions is pleased to announce Ulrike Foley as the new Head of Global Business Development and Marketing.
2025-03-26 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.
2024-11-19 | Company
The year 2023 has proven successful, especially in the United States. Revenues increased by 50 percent, with significant improvements in profit margins.
2024-11-14 | Company
Sever Pharma Solutions is proud to be prominently featured in the 2024 Citeline Annual Report on Medicon Valley.